Navigation Links
Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries
Date:6/23/2009

LAUSANNE, Switzerland, June 23 /PRNewswire/ -- Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, announced that Salvacyl(R) (also known under the trade names Moapar(R) and Salvapar(R)), was launched in Germany in May 2009, by Dr R. Pfleger GmbH. In April 2009, Salvacyl(R) was also launched on a preliminary basis in Belgium. The effective commercial launch will take place in a couple of months. Salvacyl(R) contains the active substance triptorelin, a gonadotropin releasing hormone (GnRH) agonist analogue. The product will be prescribed for the reversible reduction of serum testosterone to the level of castration in order to lower sexual drive in adult men suffering from sexual deviations.

"This is a great accomplishment for Debiopharm. Salvacyl(R) is the fourth product we have developed and made available to doctors for the treatment of a serious condition," said Rolland-Yves Mauvernay, President and Founder of Debiopharm Group. "We can now offer people suffering from this controversial disorder an alternative and a complementary treatment to surgical and currently used chemical castrations, as well as to other types of medication."

Salvacyl(R) is registered in seven other European countries, including France, the United Kingdom, Sweden, Norway, Denmark, the Netherlands and Finland, and will be launched progressively by Debiopharm's commercial partners in the course of 2009 and 2010. Moapar(R) is currently undergoing a registration procedure with Swissmedic in Switzerland.

About Salvacyl(R)

In the treatment of sexual deviations in men, intra-muscular administration of Salvacyl(R) every 3 months, in combination with psychotherapy, is an advantage over daily oral forms or intra-muscular weekly injections that are required with anti-androgens such as cyproter
'/>"/>

SOURCE Debiopharm Group
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
2. Rexinoid Developed by NuRx Pharmaceuticals Shows Promise in Prevention, Treatment of Lung, Breast Cancer, Paper in Clinical Cancer Research Reports
3. Micromet Presents Safety and Efficacy Data from Primate Studies With Two New BiTE Antibodies Developed for Treatment of Leukaemia and Melanoma
4. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
5. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
6. More Than 300 New Medicines Being Developed for Mental Illnesses
7. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
8. Rapid Test for Pathogens Developed By K-State Researchers Could Be Used to Detect Diseases Used By Bioterrorists
9. DNA Vaccine Developed at the Karmanos Cancer Institute Fights HER2-Positive Cancers
10. deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimers and Other Cognitive Disorders
11. First Breast Cancer Patient Receives Treatment in National Electronic Brachytherapy Registry Launched by Three Physician Societies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,Nov.25/PRNewswire-FirstCall/--Abaxis,Inc.(Nasdaq:...of-carebloodanalysissystems,announcedtodaythatClin...sentatthe21stAnnualPiperJaffrayHealthCareConferenc...ncewillbeheldattheNewYorkPalaceHotelinNewYorkCity....uresandmarketsportablebloodanalysissystemsforusein...
(Date:11/25/2009)...v.25/PRNewswire/--AccordingtoMillenniumResearchGro...tintelligence,thenearly$3billionUSmarketfortraumaf...extfiveyearsdespitetherecenteconomicslowdown.MRG,s...ismarketwillremainhighlydynamicoverthenextfiveyear...eviouslyunderservedsegmentsofthetraumafixationmark...
(Date:11/25/2009)...Nov.25/PRNewswire/--CempraPharmaceuticalsInc.today...fexecutiveofficer,willpresentatthePiperJaffray21st...2009,atTheNewYorkPalaceHotelinNewYorkCity.Dr.Ferna...ntibioticclinicalprogramsforthetreatmentofdrug-res...armaceuticals ,, Foundedin2006,CempraPharmaceu...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Cancer Advocacy Organization Confronts the Source of rBGH Demands Pharmaceutical Giant Eli Lilly Stop Milking Cancer 57914 1Cancer Advocacy Organization Confronts the Source of rBGH Demands Pharmaceutical Giant Eli Lilly Stop Milking Cancer 57914 2Will Jatropha Become a 26apos 3BDotCom Bubble 26apos 3B in Biofuel Industry 3F Leading to 2nd JatrophaWorld Africa Jatropha Webinar on 30 Sept 09 Ex 14196 1Will Jatropha Become a 26apos 3BDotCom Bubble 26apos 3B in Biofuel Industry 3F Leading to 2nd JatrophaWorld Africa Jatropha Webinar on 30 Sept 09 Ex 14196 2Brain Aneurysm Patients Have A New Voice With Brain Storms Blog 57908 1Brain Aneurysm Patients Have A New Voice With Brain Storms Blog 57908 2Brain Aneurysm Patients Have A New Voice With Brain Storms Blog 57908 3
.../ -- Asenapine -- an,investigational drug being de...unit of Akzo Nobel, for bipolar I disorder and,sch...e than placebo,in treating acute manic and mixed e...ing to new Phase III results, from a study,present...Annual,Meeting. , In the three-week study, patient...
... -, COLLEGEVILLE, Pa., May 21, 2007 /PRNewswire-Fi...afety and efficacy of,desvenlafaxine succinate, a ... being studied as a potential treatment for adults...ted today at the,2007 American Psychiatric Associa... Pharmaceuticals, a division of Wyeth . Results,fr...
Other Medicine Technology:Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 2Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 3Organon's Asenapine Effective in a Phase III Study for the,Treatment of Bipolar I Disorder; Results Unveiled at 2007 APA,Meeting 4New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 2New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 3New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 4New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 5New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 6New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 7New Study Results Provide Additional Data about Short- and,Long-Term Use of Desvenlafaxine Succinate in the Treatment of,Adults with Major Depressive Disorder 8
(Date:11/25/2009)...ioSpace.com, the premier resource for life science...on of the BioForest™ Hotbed Campaign this mo...ocus) November 25, 2009 -- BioSpace.com, the premi...on, unveiled the third edition of the BioForest&tr...egional campaign is a promotional effort highlight...
(Date:11/25/2009)...ShareRecordsSafely,ImproveCare ,, WASHINGTON,...ransAffairs(VA)andKaiserPermanentetodayannouncedan...urNation,sheroes.VAandKaiserPermanentearelaunching...informationusingtheNationwideHealthInformationNetw...vices. ,, "Theabilitytosharecriticalhealthinfor...
(Date:11/25/2009).../PRNewswire/--dazzlesmile,llc www.dazzlesmile.com ...ce.com havefileda67-pagefederallawsuitagainstEpicA...llms,FarendServicesLimited,andAtLastFulfillment.Th...tCourtfortheDistrictofUtah,allegesmassivenationalc...dteethwhiteningproducts,violationsoftheRacketeerin...
(Date:11/25/2009)...5/PRNewswire/--DanielTouizer,CEOof Ci n e r g...thinsurancebenefitprograms,isconcernedthatthelabor...einfiveAmericansarewithoutafull-timejobandunlikely...saredeterminedbytheU-6number,whichhasspikedto17.5%... ouizer ."Thesestatisticsarealarmingasitmeansthat...
(Date:11/25/2009)... pathways essential to normal human development - ... receptor (EGFR) pathways - interact in ways that ...searchers from The University of Texas M. D. Ander...Molecular Cell . , This newly characterized inte...to correlate with invasive cancer - activation of ...
Breaking Medicine News(10 mins):Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2Health News:VA and Kaiser Permanente Invite Veterans to Participate in Health Record Pilot Program 2Health News:dazzlesmile Sues Epic Advertising and Jesse Willms 2Health News:Cinergy Health Commentary on Health Care for the Unemployed 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3
...are being fed contaminated feed is causing concern...n the rise for the past few years//. The FDA is qu...have much human risk. This concern came to l... contaminated feed. Until the investigation more t...
...hers, diabetes is fast becoming a common reason fo... Reproductive Medicine Research Group at Queen's U...emen samples of 57 men who were diagnosed with Dia...ch samples it was seen that diabetes brought about...
...y against his wife’s decision to undergo breast en...far//. McCarthy, 27, who belonged to Canning Town...wife, Mrs. McCarthy on 9 February from the hospita...spital where she was to get a breast enlargement s...
... link between pregnancy, migraine and stroke, US r... deadly one. In fact, Cheryl Bushnell, assis... Center for Cerebrovascular Disease in Durham, exp...ating on the risk, Cheryl Bushnell said, "In addit...
...S) has been associated with altered amounts of slo...ncephalograph// (EEG) activity and impaired sleep ...journal SLEEP finds that CFS is also associated wi...eanna Armitage, PhD, and colleagues at the Univers...
..., autistic children are no more likely than other ...w research. Researchers compared blood sampl...ldren without autism who had been referred to an o...ntibodies. Biopsies of the small intestine were of...
Other Medicine News:Health News:Tainted Pet Food a Health Risk for Human? 2Health News:Fertility Rates Felled By Diabetes 2
Threaded Dilator System for ACL Tunnel Preparation
Knot Pusher
...ng soft tissue more efficiently than a punch witho...n the straight scissor helps to maintain sharpness...fficient resection.,The curved scissors, availabl...t tools for ACL stump removal, meniscectomies and ...
...e-of-the-art quality in an instrument of extremely...ility. Low profile cutting tips allow access to pa...s are available in just about every cutting tip st...oint arthroscopic procedures.,Arthrex offers a li...
Medicine Products: